Historical iex News Stories

IEX Rally: Manufacturing Rebound Boosts DataCenter

Recent U.S. manufacturing indicators and stronger factory orders have provided a favorable tailwind for IDEX Corporation (IEX). Coupled with a robust Q4 2025 showing—driven by data‑center demand in the Health & Science Technologies segment—and heightened institutional interest, IEX is positioned to benefit from renewed industrial capex and targeted end‑market growth.

IDEX Q4 Beat, HST Orders Surge; Guidance Tight

IDEX (IEX) reported a modest Q4 beat driven by a 34% surge in Health & Science Technologies orders and strong free cash flow, but guidance and softer industrial segments kept upside capped. Elevated trading and clear technical levels make the stock sensitive to macro and segment-specific news.

IEX Shares Slip as Manufacturing Data Diverges Now

IDEX (IEX) underperformed the S&P 500 this week amid mixed U.S. industrial signals: factory orders dipped while the ISM manufacturing PMI strengthened. No company-specific catalysts appeared; technicals show weakness but analysts still hold a moderate-buy consensus with upside to the average target.